Theravance Biopharma, Inc. Preferred Stock, Value, Issued
Theravance Biopharma, Inc. (TBPH) had Preferred Stock, Value, Issued of $0 as of 2020-09-30, per its 10-Q filed 2020-11-09.
Discontinued › Balance Sheet
us-gaap:PreferredStockValue · last filed 2020-11-09
- 2020-09-30: Preferred Stock, Value, Issued $0.00.
- 2020-06-30: Preferred Stock, Value, Issued $0.00.
- 2020-03-31: Preferred Stock, Value, Issued $0.00.
- 2019-12-31: Preferred Stock, Value, Issued $0.00.
| Period end | Preferred Stock, Value, Issued |
|---|---|
| 2020-09-30 | $0.00 10-Q · filed 2020-11-09 |
| 2020-06-30 | $0.00 10-Q · filed 2020-08-10 |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-08 |
| 2019-12-31 | $0.00 10-Q · filed 2020-11-09 |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-08 |
| 2019-06-30 | $0.00 10-Q · filed 2019-08-05 |
| 2018-12-31 | $0.00 10-Q · filed 2019-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |